---
id: CARD-SF005
specialty: cardiology
topic: heart-failure
difficulty: medium
type: shortform
tags: [cardiology, heartFailure, treatment, pharmacology, copilot]
created: 2025-01-09
lastUpdated: 2025-01-09
---

# Heart Failure Quick Questions

## Question 1
First medication to initiate in HFrEF:
A) Beta blocker
B) ACE inhibitor/ARB
C) Aldosterone antagonist
D) SGLT2 inhibitor

<details>
<summary>Answer</summary>
B) ACE inhibitor/ARB - Cornerstone of HFrEF therapy
</details>

## Question 2
NYHA class III heart failure is characterized by:
A) Asymptomatic
B) Symptoms with ordinary physical activity
C) Symptoms at rest
D) Symptoms with minimal exertion

<details>
<summary>Answer</summary>
D) Symptoms with minimal exertion - NYHA III represents marked limitation of physical activity
</details>

<details>
<summary>Answer</summary>
B) Symptoms with ordinary activity - Marked limitation
</details>

## Question 3
Best test to exclude diastolic dysfunction:
A) BNP
B) Echo with tissue Doppler
C) Chest X-ray
D) ECG

<details>
<summary>Answer</summary>
B) Echo with tissue Doppler - Most accurate assessment
</details>

## Question 4
Most specific physical finding for volume overload:
A) S3 gallop
B) Rales
C) JVD
D) Peripheral edema

<details>
<summary>Answer</summary>
C) JVD - Best indicator of elevated right-sided pressures
</details>

## Question 5
Target dose of carvedilol in HFrEF:
A) 3.125mg BID
B) 12.5mg BID
C) 25mg BID
D) 50mg BID

<details>
<summary>Answer</summary>
C) 25mg BID - Evidence-based target dose
</details>

## References
- ACC/AHA Heart Failure Guidelines 2023
- ESC Guidelines for Heart Failure 2022
- NEJM 2021: "Advances in Heart Failure Management"
